意美医保可以报销吗？

The first edition of the 2013 National Comprehensive Cancer Network (NCCN) Antiemetic Guidelines (hereinafter referred to as the 2013 Guidelines) has been published. Its updated content includes: prevention and treatment of acute nausea and vomiting, prevention and treatment of delayed nausea and vomiting, prevention and treatment of nausea and vomiting caused by multi-day chemotherapy, etc. It can be seen from the new version of the guidelines that neurokinin-1 (NK-1) receptor antagonists are frequently recommended for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). As the first selective, high-affinity antagonist targeting human substance P/NK-1 receptors, aprepitant has become a hot topic in clinical research and practice in recent years, and has been increasingly recognized by NCCN guidelines and clinical practice.

Aprepitant is a highly selective substance P neurokinin 1 (NK1) receptor antagonist. It can inhibit acute vomiting and delayed vomiting involving NK1 receptors by antagonizing substance P. This product received marketing authorization from the United States and the European Union in 2003. It is used in combination with other anti-vomiting drugs to prevent acute or delayed nausea and vomiting that occurs during initial or repeated chemotherapy for highly or moderately emetic tumors. It is currently approved in more than 75 countries.

This product is the first highly selective substance P neurokinin 1 (NK1) receptor antagonist. The launch of this product can bring more treatment methods to Chinese cancer patients in the prevention and treatment of acute or delayed nausea and vomiting during highly emetic chemotherapy, especially for delayed nausea and vomiting. It will bring better therapeutic effects.

Can medical insurance reimburse me? Yimei was officially approved for sale in China on August 22, 2014, and has also been included in the national medical insurance to provide everyone with government discounts to reduce their financial burden. The specifications of Yimei capsules after medical insurance are 3 capsules per box (0.125gx1 capsule + 80mgx2 capsules). The price of each box is about $600, which is still relatively high. According to Medical Companion Travel, we learned that the price of Yimei is about 60$, which is more suitable for patients to use for a long time. It is cheaper and more cost-effective. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Yimei, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.